My watch list  


Innogenetics is a Belgium-based international biopharmaceutical company, with headquarters in Ghent, Belgium. The company has two divisions: a specialty diagnostics business, and a therapeutics business that develops therapeutic vaccines.


Innogenetics was founded in 1985, by Erik Tambuyzer and Hugo Van Heuverswyn. The company was one of the first biotech companies to be listed on a European stock exchange, and currently has its shares traded on Euronext Brussels.

See also


  • Annual report
  • Jannes G, De Vos D., A review of current and future molecular diagnostic tests for use in the microbiology laboratory, Methods Mol Biol. 2006;345:1-21.
  • Tortoli E, Marcelli F.,Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility, Eur J Clin Microbiol Infect Dis. 2007, Jan;26(1):51-5.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Innogenetics". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE